Literature DB >> 22247385

Survival of bighorn sheep (Ovis canadensis) commingled with domestic sheep (Ovis aries) in the absence of Mycoplasma ovipneumoniae.

Thomas E Besser1, E Frances Cassirer, Catherine Yamada, Kathleen A Potter, Caroline Herndon, William J Foreyt, Donald P Knowles, Subramaniam Srikumaran.   

Abstract

To test the hypothesis that Mycoplasma ovipneumoniae is an important agent of the bighorn sheep (Ovis canadensis) pneumonia that has previously inevitably followed experimental commingling with domestic sheep (Ovis aries), we commingled M. ovipneumoniae-free domestic and bighorn sheep (n=4 each). One bighorn sheep died with acute pneumonia 90 days after commingling, but the other three remained healthy for >100 days. This unprecedented survival rate is significantly different (P=0.002) from that of previous bighorn-domestic sheep contact studies but similar to (P>0.05) bighorn sheep survival following commingling with other ungulates. The absence of epizootic respiratory disease in this experiment supports the hypothesized role of M. ovipneumoniae as a key pathogen of epizootic pneumonia in bighorn sheep commingled with domestic sheep.

Entities:  

Mesh:

Year:  2012        PMID: 22247385     DOI: 10.7589/0090-3558-48.1.168

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  8 in total

1.  Costs and benefits of group living with disease: a case study of pneumonia in bighorn lambs (Ovis canadensis).

Authors:  Kezia R Manlove; E Frances Cassirer; Paul C Cross; Raina K Plowright; Peter J Hudson
Journal:  Proc Biol Sci       Date:  2014-12-22       Impact factor: 5.349

2.  Experimental infection of specific-pathogen-free domestic lambs with Mycoplasma ovipneumoniae causes asymptomatic colonization of the upper airways that is resistant to antibiotic treatment.

Authors:  Thea Johnson; Kerri Jones; B Tegner Jacobson; Julia Schearer; Noah Adams; Isaak Thornton; Cassie Mosdal; Steven Jones; Mark Jutila; Agnieszka Rynda-Apple; Thomas Besser; Diane Bimczok
Journal:  Vet Microbiol       Date:  2022-01-10       Impact factor: 3.246

3.  Causes of pneumonia epizootics among bighorn sheep, Western United States, 2008-2010.

Authors:  Thomas E Besser; Margaret A Highland; Katherine Baker; E Frances Cassirer; Neil J Anderson; Jennifer M Ramsey; Kristin Mansfield; Darren L Bruning; Peregrine Wolff; Joshua B Smith; Jonathan A Jenks
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

4.  Safety and Immunogenicity of a Mycoplasma ovipneumoniae bacterin for domestic sheep (Ovis aries).

Authors:  Jessie C Ziegler; Kevin K Lahmers; George M Barrington; Steven M Parish; Katherine Kilzer; Katherine Baker; Thomas E Besser
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

5.  Exposure of bighorn sheep to domestic goats colonized with Mycoplasma ovipneumoniae induces sub-lethal pneumonia.

Authors:  Thomas E Besser; E Frances Cassirer; Kathleen A Potter; William J Foreyt
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

6.  Respiratory pathogens and their association with population performance in Montana and Wyoming bighorn sheep populations.

Authors:  Carson J Butler; William H Edwards; J Terrill Paterson; Kelly M Proffitt; Jessica E Jennings-Gaines; Halcyon J Killion; Mary E Wood; Jennifer M Ramsey; Emily S Almberg; Sarah R Dewey; Douglas E McWhirter; Alyson B Courtemanch; P J White; Jay J Rotella; Robert A Garrott
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

7.  Use of exposure history to identify patterns of immunity to pneumonia in bighorn sheep (Ovis canadensis).

Authors:  Raina K Plowright; Kezia Manlove; E Frances Cassirer; Paul C Cross; Thomas E Besser; Peter J Hudson
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

8.  Epizootic pneumonia of bighorn sheep following experimental exposure to Mycoplasma ovipneumoniae.

Authors:  Thomas E Besser; E Frances Cassirer; Kathleen A Potter; Kevin Lahmers; J Lindsay Oaks; Sudarvili Shanthalingam; Subramaniam Srikumaran; William J Foreyt
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.